A novel lung injury animal model using KL-6-measurable human MUC1-expressing mice
Authors:
- Mizu SakaiMSMizu Sakai
- Tetsuya KubotaTKTetsuya Kubota
- Hiroshi OhnishiHOHiroshi Ohnishi
- Akihito YokoyamaAYAkihito Yokoyama
- 1 March 2013
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 432 (3) , 460-465
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 21 references indexed in Scilit:
- Utility of KL-6/MUC1 in the clinical management of interstitial lung diseasesRespiratory Investigation, 2012
- Animal models of acute lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Murine models of pulmonary fibrosisAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- MUC1: A target molecule for cancer therapyCancer Biology & Therapy, 2007
- Prognostic value of circulating KL‐6 in idiopathic pulmonary fibrosisRespirology, 2006
- Non-invasive pulmonary aerosol delivery in mice by the endotracheal routeEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- Circulating KL-6 levels in patients with drug induced pneumonitisThorax, 2003
- Comparative Study of KL-6, Surfactant Protein-A, Surfactant Protein-D, and Monocyte Chemoattractant Protein-1 as Serum Markers for Interstitial Lung DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Influence of organ site and tumor cell type on MUC1-specific tumor immunityInternational Immunology, 2001
- Simple method of estimating severity of pulmonary fibrosis on a numerical scale.Journal of Clinical Pathology, 1988